Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arrington

Showing results (621-630 of 712) with videos related to

Pageof 72
Sort By:
ACS Macro Letters|June 5, 2022
High Refractive Index Copolymers with Improved Thermomechanical Properties via the Inverse Vulcanization of Sulfur and 1,3,5-TriisopropenylbenzeneTristan S Kleine, Ngoc A Nguyen, Laura E Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activityTimothy A Lewis, Michelle A Young, Mark P Arrington, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2012
Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation ratesVadim Y Dudkin, Keith Rickert, Constantine Kreatsoulas, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitorsMark E Fraley, Kenneth L Arrington, Scott R Hambaugh, et al.
American Journal of Medical Genetics. Part A|August 19, 2015
Exome analysis of a family with Wolff-Parkinson-White syndrome identifies a novel disease locusNeil E Bowles, Chuanchau J Jou, Cammon B Arrington, et al.
JTCVS Open|May 1, 2025
Gender disparities in cardiothoracic surgical conference scholarly interactions: A prime opportunity for change in cultureShanique A Ries, Emily June Zolfaghari, Adrian Higaki, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokineticsMark E Fraley, Robert S Rubino, William F Hoffman, et al.
The Journal of Cell Biology|March 13, 2013
Rer1p maintains ciliary length and signaling by regulating γ-secretase activity and Foxj1a levelsNathalie Jurisch-Yaksi, Applonia J Rose, Huiqi Lu, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 20, 2022
Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A ReviewRenata Arrington-Sanders, Nathan T Connell, Devin Coon, et al.
Pageof 72

Showing results (621-630 of 712) with videos related to

Sort By:
Pageof 72
ACS Macro Letters|June 5, 2022
High Refractive Index Copolymers with Improved Thermomechanical Properties via the Inverse Vulcanization of Sulfur and 1,3,5-TriisopropenylbenzeneTristan S Kleine, Ngoc A Nguyen, Laura E Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activityTimothy A Lewis, Michelle A Young, Mark P Arrington, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2012
Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation ratesVadim Y Dudkin, Keith Rickert, Constantine Kreatsoulas, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitorsMark E Fraley, Kenneth L Arrington, Scott R Hambaugh, et al.
American Journal of Medical Genetics. Part A|August 19, 2015
Exome analysis of a family with Wolff-Parkinson-White syndrome identifies a novel disease locusNeil E Bowles, Chuanchau J Jou, Cammon B Arrington, et al.
JTCVS Open|May 1, 2025
Gender disparities in cardiothoracic surgical conference scholarly interactions: A prime opportunity for change in cultureShanique A Ries, Emily June Zolfaghari, Adrian Higaki, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokineticsMark E Fraley, Robert S Rubino, William F Hoffman, et al.
The Journal of Cell Biology|March 13, 2013
Rer1p maintains ciliary length and signaling by regulating γ-secretase activity and Foxj1a levelsNathalie Jurisch-Yaksi, Applonia J Rose, Huiqi Lu, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 20, 2022
Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A ReviewRenata Arrington-Sanders, Nathan T Connell, Devin Coon, et al.
Pageof 72